Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications Aug 30, 2013 Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications 24 KB ... Read more Summary ToggleTekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer Aug 12, 2013 Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer 39.7 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2013 Results Aug 12, 2013 Tekmira Provides Corporate Update and Announces Second Quarter 2013 Results 39.7 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) Aug 12, 2013 Tekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) 39.7 KB Future Clinical Development Plans Outlined for Tekmira's Oncology Therapeutic, TKM-PLK1 ... Read more Summary ToggleTekmira to Present at 2013 Wedbush Life Sciences Conference Aug 07, 2013 Tekmira to Present at 2013 Wedbush Life Sciences Conference 11.7 KB ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results Aug 06, 2013 Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 12.3 KB ... Read more Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Jul 18, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19 KB Spectrum Pharmaceuticals Acquires Talon Therapeutics and Guides for Launch of Marqibo Later This Year ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data Jul 01, 2013 Tekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data 18.9 KB ... Read more Summary ToggleTekmira Announces Election of Directors May 17, 2013 Tekmira Announces Election of Directors 12.6 KB ... Read more Summary ToggleTekmira Presents LNP Technology Innovations at Scientific Symposium May 15, 2013 Tekmira Presents LNP Technology Innovations at Scientific Symposium 24.7 KB Highlights Include Advancements in LNP Potency, Lyophilization, and Subcutaneous Administration ... Read more Pagination First page First Previous page Previous … Page 34 Current page 35 Page 36 Page 37 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications Aug 30, 2013 Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications 24 KB ... Read more Summary ToggleTekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer Aug 12, 2013 Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer 39.7 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Announces Second Quarter 2013 Results Aug 12, 2013 Tekmira Provides Corporate Update and Announces Second Quarter 2013 Results 39.7 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) Aug 12, 2013 Tekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) 39.7 KB Future Clinical Development Plans Outlined for Tekmira's Oncology Therapeutic, TKM-PLK1 ... Read more Summary ToggleTekmira to Present at 2013 Wedbush Life Sciences Conference Aug 07, 2013 Tekmira to Present at 2013 Wedbush Life Sciences Conference 11.7 KB ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results Aug 06, 2013 Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 12.3 KB ... Read more Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Jul 18, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19 KB Spectrum Pharmaceuticals Acquires Talon Therapeutics and Guides for Launch of Marqibo Later This Year ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data Jul 01, 2013 Tekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data 18.9 KB ... Read more Summary ToggleTekmira Announces Election of Directors May 17, 2013 Tekmira Announces Election of Directors 12.6 KB ... Read more Summary ToggleTekmira Presents LNP Technology Innovations at Scientific Symposium May 15, 2013 Tekmira Presents LNP Technology Innovations at Scientific Symposium 24.7 KB Highlights Include Advancements in LNP Potency, Lyophilization, and Subcutaneous Administration ... Read more Pagination First page First Previous page Previous … Page 34 Current page 35 Page 36 Page 37 … Next page Next Last page Last
Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications 24 KB
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer 39.7 KB
Tekmira Initiates TKM-PLK1 Phase I/II Clinical Trial, Enrolling Patients With Advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) or Adrenocortical Carcinoma (ACC) 39.7 KB
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 12.3 KB
